The Pak2 Activator JB2019A Rescues the Pro‐Arrhythmic Effects of Acute Isoproterenol Challenge and Chronic TAC‐Induced Cardiac Hypertrophy, Reducing Mitochondrial Structural Damage and ROS Production. The gene discussed is PAK2; the disease is persistent truncus arteriosus.